Estimating the transfusion risk following total knee arthroplasty. (отвара нови прозор)

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

Извор‎: Orthopedics 2012;35(10):e1465-71.

Индекс‎: PubMed 23027481

DOI‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 (отвара нови прозор)

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. (отвара нови прозор)

Bebbington A, Kulkarni R, Roberts P.

Извор‎: J Arthroplasty 2005;20(1):125-6.

Индекс‎: PubMed 15660071

DOI‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 (отвара нови прозор)

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? (отвара нови прозор)

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

Извор‎: Can J Surg 2014;57(5):342-8.

Индекс‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 (отвара нови прозор)

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. (отвара нови прозор)

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

Извор‎: Br J Anaesth 2012;108(1):63-71.

Индекс‎: PubMed 22037224

DOI‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 (отвара нови прозор)